SNX4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.806600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.966200E-01
Normal-vs-Stage2
6.157400E-01
Normal-vs-Stage3
3.012600E-01
Normal-vs-Stage4
6.754600E-01
Stage1-vs-Stage2
1.268190E-01
Stage1-vs-Stage3
1.438410E-01
Stage1-vs-Stage4
9.379400E-01
Stage2-vs-Stage3
2.513600E-01
Stage2-vs-Stage4
1.640230E-01
Stage3-vs-Stage4
1.674370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.195600E-01
Normal-vs-AfricanAmerican
6.558800E-01
Normal-vs-Asian
8.321200E-01
Caucasian-vs-AfricanAmerican
7.880400E-02
Caucasian-vs-Asian
7.285600E-01
AfricanAmerican-vs-Asian
3.767400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.413000E-01
Normal-vs-Female
7.498800E-01
Male-vs-Female
5.322600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.919400E-01
Normal-vs-Age(41-60Yrs)
9.127200E-01
Normal-vs-Age(61-80Yrs)
5.056800E-01
Normal-vs-Age(81-100Yrs)
5.931600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.013000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.125200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.872800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.199300E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.079400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.345200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.912000E-01
Normal-vs-Daily Drinker
2.353000E-01
Normal-vs-Weekly Drinker
5.558000E-01
Normal-vs-Occasional Drinker
9.775400E-01
Normal-vs-Social Drinker
8.461800E-01
Non Drinker-vs-Daily Drinker
1.580200E-01
Non Drinker-vs-Weekly Drinker
7.031000E-01
Non Drinker-vs-Occasional Drinker
3.816800E-01
Non Drinker-vs-Social Drinker
5.388400E-01
Daily Drinker-vs-Weekly Drinker
4.768000E-01
Daily Drinker-vs-Occasional Drinker
6.516300E-02
Daily Drinker-vs-Social Drinker
8.107500E-02
Weekly Drinker-vs-Occasional Drinker
3.549400E-01
Weekly Drinker-vs-Social Drinker
4.359200E-01
Occasional Drinker-vs-Social Drinker
8.063000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.312200E-02
Normal-vs-Grade 2
6.122800E-03
Normal-vs-Grade 3
9.164900E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.952400E-01
Grade 1-vs-Grade 3
7.705000E-01
Grade 1-vs-Grade 4
6.312200E-02
Grade 2-vs-Grade 3
6.431600E-01
Grade 2-vs-Grade 4
6.122800E-03
Grade 3-vs-Grade 4
9.164900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.442600E-01
Normal-vs-NonDiabetic
6.375400E-01
Diabetic-vs-NonDiabetic
7.429900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.766600E-01
Normal-vs-NoPancreatitis
5.880600E-01
Pancreatitis-vs-NoPancreatitis
6.903800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.464200E-01
Normal-vs-N1
6.146400E-01
N0-vs-N1
4.580600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.270400E-01
Normal-vs-TP53-NonMutant
9.956000E-01
TP53-Mutant-vs-TP53-NonMutant
5.217800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
